Biopôle Lausanne’s Post

🍁 As the seasons continue to change, we take a moment to celebrate some of the latest #BiopôleNews: 🤝 Atinary Technologies has shared news of the launch of the Atinary Lab, a Self-driving Laboratory™. It will contribute to setting new standards for tackling complex challenges in the life sciences, bringing to life the potential of SDLabs™, Atinary’s no-code AI platform, alongside cutting-edge autonomous technology. 📜 cAH - centre André Henzelin has warned workers in the alternative and complementary medicine sector of the urgent need to professionalise to comply with federal regulations. 🏅 Aspivix, a leading innovator in gynecological solutions, has announced that its device, Carevix™, has been selected as one of TIME’s Best Inventions of 2024. 👁️ PeriVision has announced that it has obtained CE-marking to commercialise its first medical software product, VR- and AI-based eye testing platform VisionOne, across the EU. 🎉 Distalmotion has been granted De Novo approval by the US Food and Drug Administration (FDA) to market its flagship surgical robot Dexter for adult inguinal hernia repair. 👏 Bravo to all our members on these recent successes. Check out the full stories here: https://lnkd.in/eC6stPac

  • No alternative text description for this image

Thanks for the kind mention within this illustrious group of CH medtech startups! 🙏

Mark Lesselroth

President and CEO at BioPortUSA

1w

Congratulations to all

See more comments

To view or add a comment, sign in

Explore topics